Archive for December, 2009

Our Skin Helps Us “Hear” Speech

Wednesday, December 9th, 2009

A new study from Canada shows that our skin helps us hear speech by sensing the puffs of air that the speaker produces with certain sounds. The study is the first to show that when we are in conversation with another person we don’t just hear their sounds with our ears and use our eyes to interpret facial expressions and other cues (a fact that is already well researched), but we also use our skin to “perceive” their speech.

The study is the work of professor Bryan Gick from the Department of Linguistics, University of British Columbia, in Vancouver, Canada and PhD student Donald Derrick. A paper on their work was published in Nature on 26 November.

Gick and Derrick found that pointing puffs of air at the skin can bias the hearer’s perception of spoken syllables.

Gick, who is also a member of Haskins Laboratories, an affiliate of Yale University in the US, told the media that their findings suggest:

“We are much better at using tactile information than was previously thought.”

We are already aware of using our eyes to help us interpret speech, such as when we lip-read or observe facial features and gestures.

“Our study shows we can do the same with our skin, ‘hearing’ a puff of air, regardless of whether it got to our brains through our ears or our skin,” explained Gick.

Languages like English rely on certain syllables being aspirated, that is the speaker uses tiny and subtly differentiated bursts of breath to make the sound: for instance we distinguish “pa” from “ta” that way and we don’t use aspiration at all in sounds like “ba” and “da”.

For the study, Gick and Derrick recruited 66 men and women and asked them to distinguish among four syllables produced at the same time as inaudible air puffs (simulating aspirations) were directed at their right hand or neck. Altogether each participant heard eight repetitions of the syllables.

The results showed that when the participants heard syllables accompanied by air puffs, they were more likely to perceive them as aspirated syllables, for instance they heard “ba” as “pa” and “da” as “ta”.

In their Nature paper, Gick and Derrick wrote that other studies have examined the influence of “tactile input” but only under limited conditions, such as when perceivers were aware of the task or “where they had received training to establish a cross-modal mapping”.

This study is unique, they wrote, because it shows “that perceivers integrate naturalistic tactile information during auditory speech perception without previous training”.

They concluded that:

“These results demonstrate that perceivers integrate event-relevant tactile information in auditory perception in much the same way as they do visual information.”

Gick and Derrick hope their findings will help new developments in telecommunications, speech science and hearing aid technology.

Future studies could look at how audio, visual and tactile information interact, paving the way to a completely new approach to “multi-sensory speech perception”.

They could also look at how many kinds of speech sound are affected by air flow, giving us more insights into how we interact with our physical environment.

Additional source: University of British Columbia.

New Study Offers A Shining Light For Vitiligo Sufferers

Wednesday, December 9th, 2009

A pioneering new study could mean the end of suffering for people who live with the skin condition vitiligo.

The yearlong study, funded by the British Skin Foundation and the Vitiligo Society, will look at using a high intensity ultraviolet light source, known as Excimer, to re-pigment patches of skin affected by the skin disease. Led by Professor David Gawkrodger at the Royal Hallamshire Hospital, the team of researchers are hoping to determine whether using the particular wavelength of UV light at 380nm (nanometres) can be an effective way of reintroducing the skin’s natural pigment which is missing in skin affected by vitiligo.

There are currently few detailed scientific studies about the actual efficacy of using Excimer in vitiligo treatment, although hopes are high in the team. “Although this project will be the first use of the Excimer in this capacity in the UK, a different form of UV light treatment is already accepted as a way of treating vitiligo, known as narrow-band UVB and PUVA phototherapy. Previous studies have suggested that using Excimer can work to re-pigment the skin, so if our study confirms this, hopefully this will pave the way for greater availability of this treatment throughout the UK,” says Professor Gawkrodger.

Although the cause of vitiligo is not yet fully understood, it is commonly believed it is caused when the body makes antibodies that attack its own melanocytes, the cells which produce the skin’s pigment, melanin, resulting in white patches of skin. Vitiligo is somewhat unpredictable in that white patches can come and go of their own accord, even after treatment. Patches can slowly change their shape and size, be stable for years and for some pigment can return, but rarely completely. The affected skin, which is missing its natural ability to deal with the sun’s UV rays, is also far more likely to sunburn when compared to healthy skin.

The study will look at 20 patients with vitiligo who will each be given 20 treatments of the UV light principally to depigmented patches on the face, neck, arms or legs. The degree of repigmentation will be assessed by computer assisted analysis of photographs taken before and after treatment, with one untreated area serving as a control. In addition to this, the effect the treatment has on the patient’s quality of life will also be assessed by a series of ten questions that measures the impact of skin disorders on social and practical aspects of daily life, known widely as the Dermatology Life Quality Index (DLQI).

Matthew Patey, chief executive of the British Skin Foundation which part funded the study, says: “The fact is that current treatments for vitiligo do not always work. We still have a huge way to go before we fully understand the condition. Although it depends on the individual, the psychological impact of living with this condition can be devastating, especially if the patches of affected skin are on the face and other visible areas of the body. A loss of self confidence and social alienation are common to this and many other skin diseases, so if the tests prove successful, Professor Gawkrodger and his team hold the potential to change many lives blighted by the disease in the UK.”

Since 1984 The Vitiligo Society has been the primary source of information and support for people suffering with Vitiligo in the UK. The aim of the Vitiligo Society is not only to fund research but to help people to cope better with the psychological, social and physical impacts of the condition.

Source
The British Skin Foundation (BSF)

If you’re looking for a vitiligo cure, contact us to learn about vitiligo treatment options.

      In New Jersey, Dr. Sandy Milgraum offers several effective vitiligo treatmentoptions in his East Brunswick offices
Before
There is no cure for vitiligo, but helpful therapies do exist
After

In New Jersey, Dr. Sandy Milgraum offers several effective vitiligo treatment options in his East Brunswick offices.

New Device Enables Early Detection Of Cancerous Skin Tumors — Ben Gurion U.

Wednesday, December 9th, 2009

Researchers at Ben-Gurion University of the Negev are developing a new device that detects cancerous skin tumors, including melanomas that aren’t visible to the naked eye.

During initial testing, the OSPI instrument (Optical Spectro-Polarimetric Imaging) revealed new textures of lesions that have never been seen before – including melanoma in patients who were diagnosed with various skin lesions and were awaiting surgery for their removal. The instrument diagnosed 73 types of lesions, some of them cancerous.

Dermatologists and plastic surgeons typically diagnose skin tumors by their appearance with the naked eye and only rarely using a dermatoscope – a magnifying tool that allows tumors to be examined in detail.

The OSPI biosensor uses safe, infrared wavelengths and LC devices to measure tumor characteristics, including contours and spread.

“This is an exciting preliminary development since the initial testing shows that we can now identify microscopic tumors in the biological layers of the skin,” explains Prof. Abdulahim, who is head of the BGU Electro-Optical Unit in the Faculty of Engineering Sciences and is leading the research group. As we continue to develop the OSPI, we also see an opportunity to use this technology for detecting other types of cancerous growths.”

Cancerous mole detection is usually done by looking for one or more telltale visible symptoms: if the mole is asymmetrical; if its outline is blurred or irregular; if it has multiple colors; if it is larger than five millimeters in diameter; and if stands up above the skin.

According to the American Cancer Society, more than one million cases of skin cancer are diagnosed yearly in the United States. Melanoma, the most serious type of skin cancer, will account for about 8,650 of the 11,590 deaths due to skin cancer in 2009.

Israel has also seen a rise in skin cancer cases in recent years.

According to the Health Ministry, one of every 39 men and one of every 50 women in Israel will be affected with melanoma in their lifetime.

Prof. Ibrahim Abdulhalim is supervising this research with two students, including Ph.D. candidate Ofir Aharon and M.Sc student Avner Safrani, and is collaborating with BGU Prof. Lior Rosenberg and Dr. Ofer Arnon from the Department of Plastic Surgery at Soroka University Medical Center.

To Schedule a cancer screening contact Dr. Milgraum at his New Jersey Dermatology office at 1800-laser-18